Address
10 Sylvan Way
Parsippany, NJ 07054
United States of America (the)
Phone
973 822 7000
Website
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
13800
First IPO Date
February 01, 2013
| Name | Title | Pay | Year Born |
| Kristin C. Peck | Chief Executive Officer & Director | 5.42M | 1971 |
| Roxanne Lagano | Executive Vice President, General Counsel & Corporate Secretary | 1.44M | 1965 |
| Robert J. Polzer | Scientific Advisor | 1.45M | 1969 |
| Jamie Brannan | Executive Vice President & Chief Commercial Officer | 1.74M | 1973 |
| Wetteny N. Joseph | Executive Vice President & Chief Financial Officer | 1.8M | 1972 |
| Rimma Driscoll | EVP of Global Strategy, Portfolio Mktg. & Business Dev and Global BioDevices & Platinum Performance | 0 | 1973 |
| Jared Shriver | President of U.S. Operations | 0 | N/A |
| Julie A. Fuller | Executive Vice President, Chief Human Resources Officer & Global Operations | 0 | 1973 |
| Keith Sarbaugh | Executive Vice President & Chief Digital and Technology Officer | 0 | 1979 |
| Nick Ashton | Executive Vice President and President of Global Manufacturing & Supply | 0 | 1974 |
| Steven Frank | Vice President of Investor Relations | 0 | N/A |
| Jeannette Ferran Astorga | Executive Vice President of Corporate Affairs & Chief Sustainability Officer | 0 | 1976 |
Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.